16:23 EDT BioAge Labs (BIOA) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIOA:
- BioAge Highlights BGE-102 Progress and Financial Strength
- BIOA Earnings this Week: How Will it Perform?
- BioAge Labs price target raised to $52 from $15 at Citi
- BioAge Labs: Differentiated NLRP3 Inhibitor BGE-102 Positions Company for Best-in-Class Cardiometabolic Upside and Strategic M&A Appeal
- BioAge Labs initiated with an Outperform at Oppenheimer